To the best of our knowledge, this is the first study clearly showing that glioblastomas and anaplastic astrocytomas differ fundamentally as regards the expression of the hypoxia-related markers, HIF-1α, GLUT-1 and CA IX. This evidence concerns the gene SLC2A1 and glioblastoma.